What is YPrime?
YPrime offers a comprehensive clinical trial technology platform designed to streamline and optimize the execution of global studies. The platform integrates electronic clinical outcome assessments (eCOA), interactive response technology (IRT), and electronic consent (eConsent) solutions with configurable architecture and integrated data flows. This enables clinical trial teams to accelerate startup timelines, adapt to protocol changes efficiently, and maintain inspection-ready data quality throughout all study phases.
The technology supports complex trial designs across various therapeutic areas including oncology, rare disease, CNS, cardiometabolic, vaccines, and ophthalmology. With features that reduce site burden and improve patient engagement, YPrime helps sponsors and contract research organizations execute studies with greater speed, flexibility, and oversight while ensuring regulatory compliance and data integrity.
Features
- eCOA Platform: Enterprise-grade electronic clinical outcome assessments with pre-validated code and configurable architecture
- IRT Platform: Industry-leading interactive response technology supporting complex trial designs and rapid protocol updates
- eConsent Solution: Intuitive electronic consent that streamlines enrollment and improves patient understanding
- Patient Engagement: User-friendly design with personalization features to drive retention and adherence
- Consulting Services: Expert guidance to optimize clinical trial processes and align technology with regulatory requirements
Use Cases
- Accelerating clinical trial startup and execution timelines
- Managing complex global studies across multiple therapeutic areas
- Implementing adaptive clinical trial designs with protocol flexibility
- Ensuring regulatory compliance and inspection-ready data quality
- Improving patient engagement and retention in clinical trials
